Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapy
<p>Abstract</p> <p>Cationic (positively charged) liposomes have been tested in various gene therapy clinical trials for neoplastic and other diseases. They have demonstrated selectivity for tumour vascular endothelial cells raising hopes for both antiangiogenic and antivascular the...
Main Authors: | Choong Peter FM, Dass Crispin R |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-06-01
|
Series: | Cancer Cell International |
Online Access: | http://www.cancerci.com/content/6/1/17 |
Similar Items
-
Quantitative In Vivo Assessment of Tumour Vasculature-targeted Liposomes
by: Dunne, Michael
Published: (2010) -
Quantitative In Vivo Assessment of Tumour Vasculature-targeted Liposomes
by: Dunne, Michael
Published: (2010) -
Turning stealth liposomes into cationic liposomes for anticancer drug delivery
by: Gyanani, Vijay
Published: (2013) -
Targeting Tumour Vasculature with Oncolytic Viruses
by: De Silva, Naomi Samantha
Published: (2014) -
Targeting Tumour Vasculature as a Cancer Treatment
by: Christopher A. Honstvet, et al.
Published: (2007-01-01)